-
EP4358966
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4358966
| EP4358966 - DAPRODUSTAT FOR REDUCING FATIGUE IN A SUBJECT WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 29.03.2024 Database last updated on 19.10.2024 | |
| Former | The international publication has been made Status updated on 30.12.2022 | ||
| Former | unknown Status updated on 14.07.2021 | Most recent event Tooltip | 30.08.2024 | Change: Validation states | published on 02.10.2024 [2024/40] | 30.08.2024 | Change - extension states | published on 02.10.2024 [2024/40] | Applicant(s) | For all designated states GlaxoSmithKline Intellectual Property (No. 2) Limited GSK Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY / GB | [2024/18] | Inventor(s) | 01 /
OKORO, Tony Tochi Collegeville, Pennsylvania 19426 / US | 02 /
COBITZ, Alexander Ralph Collegeville, Pennsylvania 19426 / US | 03 /
ISRANI, Rubeen K. Collegeville, Pennsylvania 19426 / US | 04 /
BLACKORBY, Allison Barnes Research Triangle Park, North Carolina 27709 / US | 05 /
SIKIRICA, Vanja Collegeville, Pennsylvania 19426 / US | 06 /
LINDSAY, Alistair Cameron Collegeville, Pennsylvania 19426 / US | 07 /
BLUM, Steven Ira Collegeville, PA 19426 / US | [2024/18] | Representative(s) | Goddard, Carolyn Janice GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG / GB | [N/P] |
| Former [2024/18] | Goddard, Carolyn Janice GSK Global Patents CN925.1 980 Great West Road Brentford Middlesex TW8 9GS / GB | Application number, filing date | 21736741.6 | 25.06.2021 | [2024/18] | WO2021IB55708 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022269323 | Date: | 29.12.2022 | Language: | EN | [2022/52] | Type: | A1 Application with search report | No.: | EP4358966 | Date: | 01.05.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.12.2022 takes the place of the publication of the European patent application. | [2024/18] | Search report(s) | International search report - published on: | EP | 29.12.2022 | Classification | IPC: | A61K31/515, A61K9/20, A61P7/06, A61P43/00 | [2024/18] | CPC: |
A61K31/515 (EP);
A61K9/2054 (EP);
A61P43/00 (EP);
A61P7/06 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/18] | Title | German: | DAPRODUSTAT ZUR VERMINDERUNG DER ERMÜDUNG BEI EINER PERSON MIT ANÄMIE IM ZUSAMMENHANG MIT CHRONISCHER NIERENERKRANKUNG | [2024/18] | English: | DAPRODUSTAT FOR REDUCING FATIGUE IN A SUBJECT WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE | [2024/18] | French: | DAPRODUCSTAT POUR RÉDUIRE LA FATIGUE CHEZ UN SUJET SOUFFRANT D'ANÉMIE ASSOCIÉE À UNE MALADIE RÉNALE CHRONIQUE | [2024/18] | Entry into regional phase | 15.12.2023 | National basic fee paid | 15.12.2023 | Designation fee(s) paid | 15.12.2023 | Examination fee paid | Examination procedure | 15.12.2023 | Examination requested [2024/18] | 15.12.2023 | Date on which the examining division has become responsible | 23.08.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | Fees paid | Renewal fee | 15.12.2023 | Renewal fee patent year 03 | 19.06.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | by applicant | WO2019052133 | WO2020102302 | WO2021031102 |